Jincheng Wang
No. 277 Yanta West Road
Xi'an, 710061, China
Xi'an, 710061, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Feasibility of blinatumomab in newly diagnosed pediatric B-cell acute lymphoblastic leukemia patients requiring modification of standard chemotherapy.
Journal: Leukemia research
Published: March 26, 2026
Identification of a Prognostic Model Based on NK Cell-Related Genes in Multiple Myeloma Using Single-Cell and Transcriptomic Data Analysis.
Journal: Blood and lymphatic cancer : targets and therapy
Published: March 06, 2024
Glutathione-depleting Liposome Adjuvant for Augmenting the Efficacy of a Glutathione Covalent Inhibitor Oridonin for Acute Myeloid Leukemia Therapy.
Journal: Journal of nanobiotechnology
Published: December 20, 2023
VEGF-A enhances the cytotoxic function of CD4+ cytotoxic T cells via the VEGF-receptor 1/VEGF-receptor 2/AKT/mTOR pathway.
Journal: Journal of translational medicine
Published: December 16, 2022
De Novo design of a humanized antiCD33 antibody-oridonin conjugate for acute myeloid leukemia therapy.
Journal: Biochemical and biophysical research communications
Published: August 24, 2022
Kill Two Birds with One Stone: A Multifunctional Dual-Targeting Protein Drug to Overcome Imatinib Resistance in Philadelphia Chromosome-Positive Leukemia.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: October 27, 2021
Study on the Relationship Between the Expression of B Cell Mature Antigen and the Classification, Stage, and Prognostic Factors of Multiple Myeloma.
Journal: Frontiers in immunology
Published: June 13, 2021
Dynamic changes in the level of WT1 as an MRD marker to predict the therapeutic outcome of patients with AML with and without allogeneic stem cell transplantation.
Journal: Molecular medicine reports
Published: July 04, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026